Ligand · LI9
LI9 · 4-(4-fluorophenyl)-1-methyl-5-(2-{[(1S)-1-phenylethyl]amino}pyrimidin-4-yl)-2-piperidin-4-yl-1,2-dihydro-3H-pyrazol-3-one
LI9, 4-(4-fluorophenyl)-1-methyl-5-(2-{[(1S)-1-phenylethyl]amino}pyrimidin-4-yl)-2-piperidin-4-yl-1,2-dihydro-3H-pyrazol-3-one (C27 H29 F N6 O, 472.6 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every…
- Component
- LI9
- Formula
- C27 H29 F N6 O
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
LI9 in 2 structures; the first of them:
- 1YWR · Crystal Structure Analysis of inactive P38 kinase domain in complex with a Monocyclic… · LI9 A361 · binds VAL30, TYR35, VAL38, ALA51, LYS53, LEU75, ILE84, LEU86 and 12 more
- 1YWR · Crystal structure analysis of inactive P38 kinase domain in complex with a monocyclic… · LI9 A361 · binds VAL30, TYR35, VAL38, ALA51, LYS53, LEU75, ILE84, LEU86 and 12 more
Residues it binds most
LEU 2, VAL 2, ALA 2, ASP 2, ASN 2, GLY 2, HIS 2, ILE 2, LYS 2, MET 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.